MARKET

AEMD

AEMD

Aethlon Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.590
-0.300
-15.87%
Closed 19:38 08/12 EDT
OPEN
1.720
PREV CLOSE
1.890
HIGH
1.780
LOW
1.550
VOLUME
1.03M
TURNOVER
--
52 WEEK HIGH
6.89
52 WEEK LOW
0.7640
MARKET CAP
19.19M
P/E (TTM)
-0.8187
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AEMD stock price target is 13.00 with a high estimate of 13.00 and a low estimate of 13.00.

EPS

AEMD News

More
Aethlon Medical shares are trading lower after the company reported Q1 EPS results down from last year.
Benzinga · 22h ago
Aethlon Medical Q1 EPS $(0.15) Down From $(0.11) YoY
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.15) per share. This is a 36.36 percent decrease over losses of $(0.11) per share from the same period last year.
Benzinga · 1d ago
The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/3 Coronavirus Vaccine Study Starts In September
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)
Benzinga · 1d ago
Edited Transcript of AEMD earnings conference call or presentation 25-Jun-20 8:30pm GMT
Q4 2020 Aethlon Medical Inc Earnings Call
Thomson Reuters StreetEvents · 08/06 04:43
NIO, HMY among premarket gainers
Seeking Alpha - Article · 07/10 12:14
Aethlon Medical, Inc. (AEMD) CEO Timothy Rodell on Q4 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 06/26 00:21
Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update
PR Newswire · 06/25 21:15
Aethlon Medical FY20 EPS $(1.87) Up From $(5.13) YoY, Sales $650.19K Up From $229.63K YoY
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(1.87) per share. This is a 63.55 percent increase over losses of $(5.13) per share from the same period last year. The company reported $650.19 thousand in
Benzinga · 06/25 20:18

Industry

Advanced Medical Equipment & Technology
+1.95%
Healthcare Equipment & Supplies
+1.52%

Hot Stocks

Symbol
Price
%Change

About AEMD

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
More

Webull offers kinds of Aethlon Medical, Inc. stock information, including NASDAQ:AEMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AEMD stock methods without spending real money on the virtual paper trading platform.